Robaxin and Thirst - a phase IV clinical study of FDA data

Summary:

Thirst is reported as a side effect among people who take Robaxin (methocarbamol), especially for people who are female, 40-49 old, also take Oxycontin, and have Pain.

The phase IV clinical study analyzes which people have Thirst when taking Robaxin. It is created by eHealthMe based on reports of 8,252 people who have side effects when taking Robaxin from the FDA, and is updated regularly.

What is Robaxin?

Robaxin has active ingredients of methocarbamol. It is often used in muscle spasms. eHealthMe is studying from 9,109 Robaxin users. Check the latest studies of Robaxin.

What is Thirst?

Thirst is found to be associated with 1,170 drugs and 1,323 conditions by eHealthMe. Check the latest studies of Thirst.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

8,252 people reported to have side effects when taking Robaxin.
Among them, 21 people (0.25%) have Thirst.

Among these 21 people:

What is the gender of people who have Thirst when taking Robaxin? *

female: 57.14 %
male: 42.86 %

What is the age of people who have Thirst when taking Robaxin? *

What are other drugs people take besides Robaxin? *

What are other side effects people have besides Thirst? *

Joint Pain: 10 people, 47.62%
Headache (pain in head): 10 people, 47.62%
Weakness: 9 people, 42.86%
Diarrhea: 9 people, 42.86%
Pain: 8 people, 38.10%
Hypoaesthesia (reduced sense of touch or sensation): 8 people, 38.10%
Stress And Anxiety: 8 people, 38.10%
High Blood Pressure: 8 people, 38.10%
Itching: 7 people, 33.33%
Mood Swings (an extreme or rapid change in mood): 7 people, 33.33%

What are the existing conditions these people have? *

Pain: 7 people, 33.33%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 14.29%
Migraine (headache): 2 people, 9.52%
Metastases To Bone (cancer spreads to bone): 1 person, 4.76%
Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 1 person, 4.76%
Breast Cancer: 1 person, 4.76%
Chest Pain: 1 person, 4.76%
Depression: 1 person, 4.76%
Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 4.76%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Robaxin and have Thirst?

- Check whether Thirst is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Robaxin:

Robaxin (9,109 reports)

Thirst treatments and more:

Thirst (21,000 reports)

Browse all side effects of Robaxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Thirst:

Thirst (1,170 drugs)

Browse all the conditions that are associated with Thirst:

Thirst (1,323 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on methocarbamol (the active ingredients of Robaxin) and Robaxin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.